Skip to content

Phase-based treatment versus direct trauma-focused treatment in patients with Complex PTSD.

Phase-based treatment versus direct trauma-focused treatment in patients with Complex PTSD. - RCT Complex PTSD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47004
Enrollment
122
Registered
2016-05-19
Start date
2016-09-05
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

posttraumatic stress disorder trauma

Interventions

None listed

Sponsors

Dimence (Deventer)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a patient must meet all of the following criteria: a) meeting the criteria for PTSD, according to the Clinical-Administered PTSD Scale for DSM-5 (CAPS-5; Weathers et al., 2013), b) having symptoms of Complex PTSD, c) reporting a history of repeated physical and/or sexual abuse by a caretaker or person in authority during childhood (before the age of 18), d) being in the age between 18 and 65 years, e) giving an informed consent for study participation.

Exclusion criteria

Exclusion criteria: A patient who meets any of the following criteria will be excluded from participation in this study: a) insufficient competence in speaking the Dutch language, b) high risk of suicidality assessed by the BDI-II (Beck, Steer, and Brown, 1996), c) currently in treatment for PTSD, d) severe alcohol or drug dependence or abuse, e) IQ under 80, and f) victim of ongoing physical and/or sexual abuse.

Design outcomes

Primary

MeasureTime frame
The primary study parameters include the presence of a PTSD diagnosis, the severity of (Complex) PTSD symptoms, before and after completion of treatment, and at follow-up after 3 and 6 months.

Secondary

MeasureTime frame
Secondary parameters include severity of comorbid symptoms (i.e., anxiety, depression, general psychopathology), dissociation, health-related quality of life and drop out during treatment in both conditions.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)